1. 925. Infectious Complications Following Chimeric Antigen Receptor (CAR) T-cell Therapy. (4th December 2021) Authors: Trottier, Caitlin; Larsen, Christian; Bindal, Poorva; Dodge, Laura E; Elavalakanar, Pavania; Knudsen, Elisabeth; Kim, Sirwoo; Logan, Emma; Urman, Arielle R; Frigault, Matthew; Fishman, Jay A; Fishman, Jay A; Arnason, Jon; Alonso, Carolyn D Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 925. Infectious Complications Following Chimeric Antigen Receptor (CAR) T-cell Therapy. (4th December 2021) Authors: Trottier, Caitlin; Larsen, Christian; Bindal, Poorva; Dodge, Laura E; Elavalakanar, Pavania; Knudsen, Elisabeth; Kim, Sirwoo; Logan, Emma; Urman, Arielle R; Frigault, Matthew; Fishman, Jay A; Fishman, Jay A; Arnason, Jon; Alonso, Carolyn D Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Heparin induced thrombocytopenia antibodies in Covid‐19. Issue 10 (8th August 2020) Authors: Patell, Rushad; Khan, Adeel M; Bogue, Thomas; Merrill, Mwanasha; Koshy, Anita; Bindal, Poorva; Joyce, Robin; Aird, William C; Neuberg, Donna; Bauer, Kenneth A; Zwicker, Jeffrey I Journal: American journal of hematology Issue: Volume 95:Issue 10(2020:Oct.) Page Start: E295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19. (23rd August 2020) Authors: Patell, Rushad; Bogue, Thomas; Bindal, Poorva; Koshy, Anita; Merrill, Mwanasha; Aird, William C.; Bauer, Kenneth A.; Zwicker, Jeffrey I. Journal: Journal of thrombosis and haemostasis Issue: Volume 18:Number 9(2020) Page Start: 2349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab. (January 2021) Authors: Kethireddy, Nikhila; Thomas, Steffi; Bindal, Poorva; Shukla, Prateek; Hegde, Upendra Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 1(2021) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nivolumab-induced hepatitis: A rare side effect of an immune check point inhibitor. (March 2020) Authors: Mathew Thomas, Vinay; Bindal, Poorva; Ann Alexander, Swetha; McDonald, Kymberly Journal: Journal of oncology pharmacy practice Issue: Volume 26:Number 2(2020) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Potential role of rituximab in metastatic castrate-resistant prostate cancer. (September 2019) Authors: Bindal, Poorva; Jalil, Sharif AA; Holle, Lisa M; Clement, Jessica M Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 6(2019) Page Start: 1509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Primary Bone Lymphoma: A Case Series and Review of Literature. (10th April 2020) Authors: Bindal, Poorva; Desai, Aakash; Delasos, Lukas; Mulay, Sudhanshu; Vredenburgh, James Other Names: González-López Tomás J. Academic Editor. Journal: Case reports in hematology Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Therapeutic dendritic cell cancer vaccines in hematologic malignancies. Issue 1 (5th May 2021) Authors: Bindal, Poorva; Rosenblatt, Jacalyn; Avigan, David Other Names: Avigan David guestEditor. Journal: Immunomedicine Issue: Volume 1:Issue 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Time to SARS‐CoV‐2 clearance among patients with cancer and COVID‐19. (9th February 2021) Authors: Xu, Wenxin; Piper‐Vallillo, Andrew J.; Bindal, Poorva; Wischhusen, Jonathan; Patel, Jaymin M.; Costa, Daniel B.; Peters, Mary Linton B. Journal: Cancer medicine Issue: Volume 10:Number 5(2021) Page Start: 1545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗